Anlægsbærere for fragilt X-syndrom kan udvise et bredt spektrum af kliniske manifestationer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Anlægsbærere for fragilt X-syndrom kan udvise et bredt spektrum af kliniske manifestationer. / Jønch, Aia Elise; Grønskov, Karen; Carlsen Lunding, Jytte Merete; Nielsen, Jørgen E; Brøndum-Nielsen, Karen.
I: Ugeskrift for Laeger, Bind 176, Nr. 26, V02140099, 23.06.2014, s. 2-6.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Anlægsbærere for fragilt X-syndrom kan udvise et bredt spektrum af kliniske manifestationer
AU - Jønch, Aia Elise
AU - Grønskov, Karen
AU - Carlsen Lunding, Jytte Merete
AU - Nielsen, Jørgen E
AU - Brøndum-Nielsen, Karen
PY - 2014/6/23
Y1 - 2014/6/23
N2 - Carriers of fragile X syndrome can present with a broad spectrum of clinical disordersFragile X syndrome, fragile X-associated tremor/ataxia syndrome (FXTAS) and fragile X-associated primary ovarian insufficiency (FXPOI) are three clinically distinct disorders caused by expansions of a CGG repeat sequence in the non-coding part of the FMR1. FXTAS and FXPOI are seen in carriers of smaller repeat expansions (55-200). Carriers were for many years thought to be clinically unaffected, but along with the discovery of FXPOI and FXTAS a growing number of additional clinical manifestations have been identified. We wish to make Danish physicians more aware of these conditions which we review in this paper.
AB - Carriers of fragile X syndrome can present with a broad spectrum of clinical disordersFragile X syndrome, fragile X-associated tremor/ataxia syndrome (FXTAS) and fragile X-associated primary ovarian insufficiency (FXPOI) are three clinically distinct disorders caused by expansions of a CGG repeat sequence in the non-coding part of the FMR1. FXTAS and FXPOI are seen in carriers of smaller repeat expansions (55-200). Carriers were for many years thought to be clinically unaffected, but along with the discovery of FXPOI and FXTAS a growing number of additional clinical manifestations have been identified. We wish to make Danish physicians more aware of these conditions which we review in this paper.
M3 - Tidsskriftartikel
C2 - 25294575
VL - 176
SP - 2
EP - 6
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 26
M1 - V02140099
ER -
ID: 137201363